Rybelsus for Weight Loss Without Diabetes: Results, Access
Yes. Rybelsus is FDA approved for type 2 diabetes: used along with diet and exercise, it brings blood sugar down in adults with type 2 diabetes. In STEP 2, people on Wegovy lost 9.6% of body weight on average, vs 3.4% on placebo.
- For type 2 diabetes
- FDA approved
- Active ingredient
- semaglutide
- How it is taken
- daily tablet
- Best result (STEP 2)
- 9.6% weight loss
Rybelsus in brief
About 1 week is the half-life: after 7 d half is gone, and roughly 3% remains at five half-lives (35 d).
In PIONEER 1, people with type 2 diabetes lost 3.7 kg over 26 weeks, while those on placebo lost 1.4 kg.
In US dollars, monthly prices include the list price and self-pay offers. Each figure comes from the maker's price page.
Sources: FDA label (DailyMed), healthsystemtracker.org, Novo Nordisk pricing, Novo Nordisk.
Who qualifies?
| Source | Who qualifies |
|---|---|
| FDA label | Used along with diet and exercise, it brings blood sugar down in adults with type 2 diabetes. |
| FDA label | In adults with type 2 diabetes and high risk, it lowers the chance of heart attack, stroke, or death tied to the heart. |
Sources cited here: FDA label on DailyMed.
Results of trials in type 2 diabetes
Rybelsus has not been tested alone in this group. The studies listed cover brands with that same ingredient.
| Trial | Medicine | Who took part | Length | People | Main result | Comparison |
|---|---|---|---|---|---|---|
| STEP 2 |  Wegovy | Adults with obesity or overweight who also have type 2 diabetes | 68 weeks | 1,210 | 9.6% weight loss | 3.4% on placebo |
Trial sources: STEP 2 (PubMed).
Coverage for type 2 diabetes
| What changes | What the label says |
|---|---|
| Diabetic Retinopathy Complications | Eye disease from diabetes can get worse in people with type 2 diabetes, particularly when blood sugar falls quickly. Eye checks matter if you already have it. |
| Low blood sugar when insulin secretagogues or insulin are used at the same time | When it is used with insulin or a sulfonylurea, low blood sugar becomes more likely, and those drugs may need lower doses. |
| Taken with insulin or sulfonylureas | If you take it with insulin, or with a sulfonylurea such as glipizide or glimepiride, the chance of low blood sugar goes up, and the doctor may lower those doses. |
From the FDA labels: FDA label (DailyMed).
The FDA label on DailyMed lists these warnings.
Coverage for type 2 diabetes
For diabetes or cardiovascular disease, when these medicines are prescribed, Medicare Part D can pay for them.
Sources: humana.com.
Alternatives for type 2 diabetes
| Medicine | For type 2 diabetes | How it is taken | Trial result |
|---|---|---|---|
| Rybelsus | FDA approved | daily tablet | Not listed |
 Ozempic | FDA approved | weekly injection | Not listed |
 Mounjaro | FDA approved | weekly injection | A1C down 2.3 points |
 Trulicity | FDA approved | weekly injection | A1C down 1.77 points |
 Victoza | FDA approved | daily injection | Not listed |
| Byetta | FDA approved | twice-daily injection | Not listed |
| Wegovy | Not an approved use | weekly injection or daily tablet | 9.6% weight loss |
 Zepbound | Not an approved use | weekly injection | 14.7% weight loss |
 Foundayo | Not an approved use | daily tablet | 9.6% weight loss |
 Saxenda | Not an approved use | daily injection | 7.4% weight loss |
Sources: FDA label (DailyMed), PubMed.
Ask your prescriber these questions
- Will my other diabetes medicines need changes, especially my insulin or a sulfonylurea?
- I need my eyes checked. How often?
- What A1C number should I aim for?
Read the complete Rybelsus prescribing information on DailyMed.